The FDA is amending its food additive regulations in response to two food additive petitions, to no longer allow for the use of a total of 7 synthetic flavoring substances and flavor enhancers (adjuvants).
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
The FDA is amending its food additive regulations in response to two food additive petitions, to no longer allow for the use of a total of 7 synthetic flavoring substances and flavor enhancers (adjuvants).
The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended restricting the use of fluoroquinolone and quinolone antibiotics (used by mouth, injection or inhalation) following a review of disabling and potentially long-lasting side effects reported with these medicines. The review incorporated the views of patients, healthcare professionals and academics presented at EMA’s public hearing on fluoroquinolone and quinolone antibiotics in June 2018.
As part of the U.S. Food and Drug Administration’s efforts to promote drug competition and patient access, there are advanced many policies aimed at making it more efficient to bring generic competition to the market. These are drugs that, by nature of their formulation or delivery systems for example, are harder to “genericize” under our traditional approaches. As a result, these drugs often face less competition.
The embassy at Beijing, China state that Guiyang city expressing interest to procure medicines from Indian companies.
During the visit to Guiyang the officials from department of commerce and Pharmexcil along with leading exporters from India pharma companies are expected to discuss various issues with the Chinese government particularly with regard to fast track registration and speedy clearance for supply of medicines from India.
US Food and Drug Administration (FDA) has approved Hemlibra® (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with haemophilia A without factor VIII inhibitors.
The Fragrance Ingredients Market is set to grow from its current market value of more than $11.5 billion to over $18.5 billion by 2024; as reported in the latest study by Global Market Insights, Inc.
Growing penetration rate of international brands, rising demand for personal care products along with growth in cosmetics industry will drive overall fragrance ingredients market demand. These compounds are mixed with personal care products to improve aroma and give freshness to a product. Growing customer spending on beauty products including creams and perfumes supported by growing ageing population may boost industry growth.
The Conference of Parties to the WHO Framework Convention for Tobacco Control (FCTC) opens its eighth session (COP 8), with a view to defining a roadmap for strengthening and expanding the scope of the landmark global health treaty.
India has continued WHO engagement to support India maintain international quality surveillance for poliovirus detection in the country.
There have been reports in a section of the print media mentioning that bivalent oral polio vaccine supplied by a particular manufacturer had some quality issues. India was certified polio-free in March 2014 and continues to be so. India continues to remain vigilant against all three types of polioviruses. The last polio case due to wild poliovirus in the country was detected on 13 January 2011.
Continuing its efforts to promote medical technology in the country, Andhra Pradesh MedTech Zone (AMTZ) organised a mega business conference meeting ‘MedAsia Business Forum’ in the city.
The European Medicines Agency (EMA) and the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) have published a joint action plan to support the development of medicines for children in Europe.